Behavioral phenotyping: A tool for personalized medicine

Personalized Medicine

Volumn 7, Issue 6, 2010, Pages 689-693

  Kvedar, Joseph ^a,b   Jethwani, Kamal ^a,b   Kvedar, Julie ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PARTNERS HEALTHCARE   (United States)

Author keywords

behavior change; connected health; genotype; personalized medicine; phenotype; population phenotyping

Indexed keywords

ARTICLE; FEASIBILITY STUDY; GENE MAPPING; HEALTH BEHAVIOR; HEALTH CARE; HEALTH PROGRAM; MEDICINE; PERSONALIZED MEDICINE; PHENOTYPE; POPULATION; PRIORITY JOURNAL;

EID: 78650033336     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.10.62     Document Type: Article

References (14)

1. Meyer JM, Ginsburg GS: The path to personalized medicine. Curr. Opin. Chem. Biol. 6(4), 434-438 (2002).
2. Hamburg MA, Collins FS: The path to personalized medicine. N. Engl. J. Med. 363(4), 301-304 (2010).
3. Roukos DH: Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann. Surg. Oncol. 16, 795-798 (2009).
4. Lettre G, Rioux JD: Autoimmune diseases: insights from genome-wide association studies. Hum. Mo l. Genet. 17(R2), R116-R121 (2008).
5. Lesko LJ: Personalized medicine: elusive dream or imminent reality? Clin. Pharmacol. Ther. 81(6), 801-805 (2007).
6. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ: A critical appraisal of the scientifc basis of commercial genomic profles used to assess health risks and personalize health interventions. Am. J. Hum. Genet. 83(1), 130; author reply 131 (2008).
7. Joost HG: Prevention of complex diseases by genotype-based nutrition: realistic concept or fction? J. Mol. Med. 85(2), 103-105 (2007).
8. Vermeire S: Genetic susceptibility and application of genetic testing in clinical management of infammatory bowel disease. Aliment. Pharmacol. Ther. 24(Suppl. 3), 2-10 (2006).
9. Bergen SE, Maher BS, Fanous AH, Kendler KS: Detection of susceptibility genes as modifers due to subgroup differences in complex disease. Eur. J. Hum. Genet. 18(8), 960-964 (2010).
10. Mitri Z, Esmerian MO, Simaan JA, Sabra R, Zgheib NK: Pharmacogenetics and personalized medicine: the future for drug prescribing. J. Med. Liban. 58(2), 101-104 (2010).
11. Ouzounian M, Lee DS, Gramolini AO, Emili A, Fukuoka M, Liu PP: Predict, prevent and personalize: genomic and proteomic approaches to cardiovascular medicine. Can. J. Cardiol. 23(Suppl. A), 28A-33A (2007).
12. Shabo A: Integrating genomics into clinical practice: standards and regulatory challenges. Curr. Opin. Mol. Ther. 10(3), 267-272 (2008).
13. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ: A critical appraisal of the scientifc basis of commercial genomic profles used to assess health risks and personalize health interventions. Am. J. Hum. Genet. 82(3), 593-599 (2008).
14. Christakis N, Fowler J: Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives. Hachette Book Group, NY, USA (2009).